Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GSK and Vertex’ Lexiva/r added to HIV treatment guidelines
Lexiva (fosamprenavir calcium) is indicated in combination with other antiretroviral agents for the treatment of HIV infection in adults. It was approved by the FDA for use in
Lexiva (fosamprenavir calcium) is indicated in combination with other antiretroviral agents for the treatment of HIV infection in adults. It was approved by the FDA for use in
The FDA was expected to make a decision on the filing by August 17, 2006, but, having deemed the additional information recently requested for the application a major
MK-0518 belongs to a new class of investigational antiretroviral therapy agents called integrase inhibitors that inhibit the insertion of the HIV viral DNA into human DNA. The phase
Atripla contains 600mg of efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), 200mg of emtricitabine and 300mg of tenofovir disoproxil fumarate, both nucleoside reverse transcriptase inhibitors (NRTIs). Efavirenz is
The study reveals that 10% of chemotherapeutic medications for outpatients were prescribed or administered incorrectly. Although most were of little clinical significance, in some patients the errors may
The findings come from a study of 1,837 pregnant women who were surveyed in the waiting rooms of five Michigan obstetrics clinics, using a standard questionnaire that detects
The study, named SPIRIT IV, will enroll approximately 1,125 patients at around 40 sites in the US. The study allows for the treatment of up to three de
With a new parliament, Singapore’s Ministry of Health (MOH) is reviewing its existing strategies and programs, with a view to formulating new priorities for the next five years.
With the FDA’s backing, Amarillo now aims to begin a 60-patient phase II study to test low-dose oral interferon as a treatment of chronic cough in idiopathic pulmonary
Nagarkatti joined the company in 1976 and held roles in R&D, production, operations and sales before being elected president and chief operating officer in 2004. Toan is the